|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"pei jer chen"
Showing items 716-740 of 883 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T14:59:38Z |
Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort study
|
Yeh, Yi-Chun;Liu, Chun-Jen;Kuo, Raymond Nienchen;Lai, Chiu-Ling;Shau, Wen-Yi;Chen, Pei-Jer;Lai, Mei-Shu; Yeh, Yi-Chun; NIEN-CHEN KUO; Yeh, Yi-Chun; CHUN-JEN LIU; Liu, Chun-Jen; Kuo, Raymond Nienchen; Kuo, Raymond Nienchen; PEI-JER CHEN; Lai, Chiu-Ling; Lai, Chiu-Ling; Shau, Wen-Yi; Shau, Wen-Yi; Chen, Pei-Jer; Lai, Mei-Shu; Lai, Mei-Shu |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, H.-R. and Kao, J.-H. and Wu, H.-L. and Chen, T.-C. and Tseng, T.-C. and Liu, C.-H. and Su, T.-H. and Chen, P.-J. and Chen, D.-S. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; Cheng, Huei-Ru; CHUN-JEN LIU; PEI-JER CHEN; Kao, Jia-Horng; CHEN-HUA LIU; Wu, Hui-Lin; DING-SHINN CHEN; Chen, Ting-Chih; Tseng, Tai-Chung; TUNG-HUNG SU; Liu, Chen-Hua; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Liu, Chen-Hua; Liu, Chen-Hua; Lin, L. -Y.; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng; 林亮宇; 陳保中; 林俊立; 江福田; 吳卓鍇; 黃瑞仁; 蔡佳醍; 陳祈玲; Tseng, T.-C. and Liu, C.-J. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Wan-Ting;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Wu, C. -K.; Tseng, Tai-Chung; HUNG-CHIH YANG; Liu, Chun-Jen; Yang, Y. -H.; Liu, Chun-Jen; CHUN-JEN LIU; Yang, Wan-Ting; Yang, Wan-Ting; PEI-JER CHEN; Lin, T. -T.; CHEN-HUA LIU; Tsai, C. -T.; Chen, Chi-Ling; Yang, Hung-Chih; DING-SHINN CHEN; Hwang, J. -J.; Yang, Hung-Chih; Su, Tung-Hung; TUNG-HUNG SU; Lin, J. -L.; Su, Tung-Hung; Wang, Chia-Chi; Chen, P. -C.; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Chiang, F. -T. |
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T14:57:14Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Yu, Ming-Whei; Yu, Ming-Whei; Lee, Shou-Dong; Chen, Pei-Jer; Lee, Shou-Dong; Chen, Pei-Jer; Chen, Pei-Jer; Lin, Shi-Ming; Lin, Shi-Ming; Liaw, Yun-Fan; Liaw, Yun-Fan; Liu, Chun-Jen; Liu, Chun-Jen; Cheng, Hsiang-Yun;Kang, Pei-Jen;Chuang, Ya-Hui;Wang, Ya-Hui;Jan, Meng-Chin;Wu, Chih-Feng;Lin, Chih-Lin;Liu, Chun-Jen;Liaw, Yun-Fan;Lin, Shi-Ming;Chen, Pei-Jer;Lee, Shou-Dong;Yu, Ming-Whei; MING-WHEI YU; Cheng, Hsiang-Yun; CHUN-JEN LIU; Kang, Pei-Jen; PEI-JER CHEN; Chuang, Ya-Hui; Chuang, Ya-Hui; Wang, Ya-Hui; YA-HUI CHUANG; Jan, Meng-Chin; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:57:12Z |
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
|
Chu, Yu-Tseng; Chu, Yu-Tseng; CHUN-JEN LIU; Chu, Yu-Tseng; PEI-JER CHEN; Shau, Wen-Yi; Shau, Wen-Yi; Shau, Wen-Yi; Kuo, Raymond N.; Kuo, Raymond N.; Chen, Pei-Jer; Lai, Mei-Shu; Lai, Mei-Shu; Liu, Chun-Jen;Chu, Yu-Tseng;Shau, Wen-Yi;Kuo, Raymond N.;Chen, Pei-Jer;Lai, Mei-Shu; Liu, Chun-Jen; Liu, Chun-Jen; NIEN-CHEN KUO |
| 臺大學術典藏 |
2018-09-10T14:51:19Z |
Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan
|
Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chien-Jen; Yang, Wei-Shiung; PEI-JER CHEN; WEI-SHIUNG YANG; Yang, Hwai-I; Chen, Chuen-Fei; DING-SHINN CHEN; JIA-HORNG KAO; You, San-Lin; Wang, Li-Yu; Lu, Sheng-Nan; Lu, Sheng-Nan; Liu, Chun-Jen; Yang, Wei-Shiung; CHUN-JEN LIU; Chen, Chi-Ling; Chen, Chi-Ling;Yang, Wei-Shiung;Yang, Hwai-I;Chen, Chuen-Fei;You, San-Lin;Wang, Li-Yu;Lu, Sheng-Nan;Liu, Chun-Jen;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chien-Jen; Chen, Chi-Ling |
| 臺大學術典藏 |
2018-09-10T14:50:10Z |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin;Kao, Jia-Horng;Chen, Ting-Chih;Wu, Wen-Hsuan;Liu, Chen-Hua;Su, Tung-Hung;Yang, Hung-Chih;Chen, Ding-Shinn;Chen, Pei-Jer;Liu, Chun-Jen; Wu, H.-L. and Kao, J.-H. and Chen, T.-C. and Wu, W.-H. and Liu, C.-H. and Su, T.-H. and Yang, H.-C. and Chen, D.-S. and Chen, P.-J. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Wu, Hui-Lin; HUNG-CHIH YANG; Kao, Jia-Horng; CHUN-JEN LIU; Kao, Jia-Horng; PEI-JER CHEN; Chen, Ting-Chih; Chang, Julia Yu-Fong; CHEN-HUA LIU; Wu, Wen-Hsuan; Liu, Chen-Hua; TUNG-HUNG SU; Liu, Chen-Hua; Su, Tung-Hung; DING-SHINN CHEN; Su, Tung-Hung; JIA-HORNG KAO; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Chen, Pei-Jer; Liu, Chun-Jen; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.
|
Chen, Ming-Yao;Liu, Chen-Hua;Chen, Ting-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;Liu, Chun-Jen; 陳定信;高嘉宏;劉俊人;陳培哲; Chen, Ming-Yao; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Chen, Ting-Chih; Su, Tung-Hung; TUNG-HUNG SU; Chang, Wen-Hsiung; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:49:23Z |
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers
|
Tseng, T.-C., Liu, C.-J., Chen, C.-L., Yang, H.-C., Su, T.-H., Wang, C.-C., Yang, W.-T., Kuo, S.F.-T., Liu, C.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; TUNG-HUNG SU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:49:23Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Liu, Wei-Liang;Chen, Chi-Ling;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Liu, Wei-Liang; DING-SHINN CHEN; Chen, Chi-Ling; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chun-Jen; Liu, Chun-Jen; CHUN-JEN LIU; Chen, Pei-Jer; PEI-JER CHEN; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, T.-H., Liu, C.-J., Tseng, T.-C., Liu, C.-H., Yang, H.-C., Chen, C.-L., Chen, P.-J., Kao, J.-H., Chen, D.-S.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Chen, Chi-Ling;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; Liu, Chun-Jen; PEI-JER CHEN; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; TUNG-HUNG SU; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Chi-Ling; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:25Z |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan, Quan;Song, Liu-Wei;Liu, Chun-Jen;Li, Zhuo;Liu, Ping-Guo;Huang, Cheng-Hao;Yan, Yan;Ge, Sheng-Xiang;Wang, Ying-Bin;Peng, Cheng-Yuan;Zhang, Jun;Kao, Jia-Horng;Chen, Ding-Shinn;Chen, Pei-Jer;Xia, Ning-Shao; CHUN-JEN LIU; Yuan, Quan; Song, Liu-Wei; PEI-JER CHEN; DING-SHINN CHEN; Liu, Chun-Jen; JIA-HORNG KAO; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao |
| 臺大學術典藏 |
2018-09-10T09:47:24Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, T.-H. and Liu, C.-H. and Liu, C.-J. and Chen, C.-L. and Ting, T.-T. and Tseng, T.-C. and Chen, P.-J. and Kao, J.-H. and Chen, D.-S.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Chi-Ling; TUNG-HUNG SU; Ting, Te-Tien; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers
|
Liu, Wan-Hsin; Chen, Chao-Hung; Yeh, Kun-Huei; Li, Chiao-Ling; Wu, Yi-Jinn; Chen, Ding-Shinn; Chen, Pei-Jer; Yeh, Shiou-Hwei; Jin, Dong-Yan; Liu, W.-H. and Chen, C.-H. and Yeh, K.-H. and Li, C.-L. and Wu, Y.-J. and Chen, D.-S. and Chen, P.-J. and Yeh, S.-H.; PEI-JER CHEN; Liu, Wan-Hsin; Chen, Chao-Hung; KUN-HUEI YEH; DING-SHINN CHEN; Yeh, Kun-Huei; SHIOU-HWEI YEH; Li, Chiao-Ling; Wu, Yi-Jinn; Chen, Ding-Shinn; Chen, Pei-Jer; Yeh, Shiou-Hwei; Jin, Dong-Yan |
| 臺大學術典藏 |
2018-09-10T09:42:01Z |
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
|
Lin, Wei-Hsiang;Yeh, Shiou-Hwei;Yang, Wan-Jen;Yeh, Kun-Huei;Fujiwara, Toshiyoshi;Nii, Aisuke;Chang, Stanley Shi-Chung;Chen, Pei-Jer; Lin, W.-H. and Yeh, S.-H. and Yang, W.-J. and Yeh, K.-H. and Fujiwara, T. and Nii, A. and Chang, S.S.-C. and Chen, P.-J.; 葉坤輝 ;葉秀慧 ;陳培哲; 葉坤輝 ;葉秀慧 ;陳培哲; Lin, Wei-Hsiang; PEI-JER CHEN; Yeh, Shiou-Hwei; Yeh, Shiou-Hwei; KUN-HUEI YEH; Yeh, Shiou-Hwei; SHIOU-HWEI YEH; Yang, Wan-Jen; Yeh, Kun-Huei; Yeh, Kun-Huei; Fujiwara, Toshiyoshi; Nii, Aisuke; Chang, Stanley Shi-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Hsu, Cheng-An;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; CHUN-JEN LIU; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; Wang, Chia-Chi; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:26:15Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
MING-WHEI YU; Shih, Wei-Liang; Chang, Hung-Chuen; CHUN-JEN LIU; Liaw, Yun-Fan; Liaw, Yun-Fan; PEI-JER CHEN; Lin, Shi-Ming; Lin, Shi-Ming; WEI-LIANG SHIH; Lee, Shou-Dong; Lee, Shou-Dong; Chen, Pei-Jer; Chen, Pei-Jer; Liu, Chun-Jen; Liu, Chun-Jen; Lin, Chih-Lin; Lin, Chih-Lin; Yu, Ming-Whei; Shih, Wei-Liang;Chang, Hung-Chuen;Liaw, Yun-Fan;Lin, Shi-Ming;Lee, Shou-Dong;Chen, Pei-Jer;Liu, Chun-Jen;Lin, Chih-Lin;Yu, Ming-Whei |
Showing items 716-740 of 883 (36 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
|
